In a significant development, Petriage announced that the U.S. Patent and Trademark Office has informed the B2B pet health technology company that new patent No.11355249, its second, will be issued on June 7, 2022. Unlike the industry-first patent for its remote pet symptom analysis tool, this patent encompasses teletriage for all animals, including humans.
The patent signals that Petriage can potentially further develop its unique AI-driven symptom analysis and triage technology to provide similar telehealth solutions for human health care. While likely years away, such services could include state-of-the-art features that its online triage system for pets already offers. These include a symptom analysis tool to identify human ailments with increasing levels of urgency, virtual consultations with physicians and automated remote monitoring, among others.
Petriage CEO Joe Coury says that, for the present, the company intends to continue expanding the services it offers veterinarians and pet owners. “But with our sophisticated machine learning component that continues to realize richer and richer data, we could envision using such learnings to provide humans with the right telehealth information at the right time.”
Discussion about this post